Click for best price
Small Molecule Targeted Anticancer Drug Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Small Molecule Targeted Anti-cancer Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Targeted Anti-cancer Drug. This report contains market size and forecasts of Small Molecule Targeted Anti-cancer Drug in global, including the following market information:
Global Small Molecule Targeted Anti-cancer Drug Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Small Molecule Targeted Anti-cancer Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
EGFR Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Small Molecule Targeted Anti-cancer Drug include Astrazeneca, Novartis, Millennium Pharmaceuticals, Bayer, Exelixis, Abbvie, Boehringer-Ingelheim, Eisai and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Small Molecule Targeted Anti-cancer Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Small Molecule Targeted Anti-cancer Drug Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Small Molecule Targeted Anti-cancer Drug Market Segment Percentages, by Type, 2022 (%)
EGFR
ALK
Bcr-Abl
Others
Global Small Molecule Targeted Anti-cancer Drug Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Small Molecule Targeted Anti-cancer Drug Market Segment Percentages, by Application, 2022 (%)
Liver Cancer
Colorectal Cancer
Lung Cancer
Gastric Cancer
Breast Cancer
Esophageal Cancer
Others
Global Small Molecule Targeted Anti-cancer Drug Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Small Molecule Targeted Anti-cancer Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Small Molecule Targeted Anti-cancer Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Small Molecule Targeted Anti-cancer Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astrazeneca
Novartis
Millennium Pharmaceuticals
Bayer
Exelixis
Abbvie
Boehringer-Ingelheim
Eisai
Pfizer
Bristol-Myers Squibb
Roche
Bettapharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Small Molecule Targeted Anti-cancer Drug, market overview.
Chapter 2: Global Small Molecule Targeted Anti-cancer Drug market size in revenue.
Chapter 3: Detailed analysis of Small Molecule Targeted Anti-cancer Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Small Molecule Targeted Anti-cancer Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Small Molecule Targeted Anti-cancer Drug Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Small Molecule Targeted Anti-cancer Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Small Molecule Targeted Anti-cancer Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Small Molecule Targeted Anti-cancer Drug Overall Market Size
2.1 Global Small Molecule Targeted Anti-cancer Drug Market Size: 2022 VS 2030
2.2 Global Small Molecule Targeted Anti-cancer Drug Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Small Molecule Targeted Anti-cancer Drug Players in Global Market
3.2 Top Global Small Molecule Targeted Anti-cancer Drug Companies Ranked by Revenue
3.3 Global Small Molecule Targeted Anti-cancer Drug Revenue by Companies
3.4 Top 3 and Top 5 Small Molecule Targeted Anti-cancer Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Small Molecule Targeted Anti-cancer Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Small Molecule Targeted Anti-cancer Drug Players in Global Market
3.6.1 List of Global Tier 1 Small Molecule Targeted Anti-cancer Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Small Molecule Targeted Anti-cancer Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Small Molecule Targeted Anti-cancer Drug Market Size Markets, 2022 & 2030
4.1.2 EGFR
4.1.3 ALK
4.1.4 Bcr-Abl
4.1.5 Others
4.2 By Type - Global Small Molecule Targeted Anti-cancer Drug Revenue & Forecasts
4.2.1 By Type - Global Small Molecule Targeted Anti-cancer Drug Revenue, 2018-2023
4.2.2 By Type - Global Small Molecule Targeted Anti-cancer Drug Revenue, 2024-2030
4.2.3 By Type - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Small Molecule Targeted Anti-cancer Drug Market Size, 2022 & 2030
5.1.2 Liver Cancer
5.1.3 Colorectal Cancer
5.1.4 Lung Cancer
5.1.5 Gastric Cancer
5.1.6 Breast Cancer
5.1.7 Esophageal Cancer
5.1.8 Others
5.2 By Application - Global Small Molecule Targeted Anti-cancer Drug Revenue & Forecasts
5.2.1 By Application - Global Small Molecule Targeted Anti-cancer Drug Revenue, 2018-2023
5.2.2 By Application - Global Small Molecule Targeted Anti-cancer Drug Revenue, 2024-2030
5.2.3 By Application - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Small Molecule Targeted Anti-cancer Drug Market Size, 2022 & 2030
6.2 By Region - Global Small Molecule Targeted Anti-cancer Drug Revenue & Forecasts
6.2.1 By Region - Global Small Molecule Targeted Anti-cancer Drug Revenue, 2018-2023
6.2.2 By Region - Global Small Molecule Targeted Anti-cancer Drug Revenue, 2024-2030
6.2.3 By Region - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Small Molecule Targeted Anti-cancer Drug Revenue, 2018-2030
6.3.2 US Small Molecule Targeted Anti-cancer Drug Market Size, 2018-2030
6.3.3 Canada Small Molecule Targeted Anti-cancer Drug Market Size, 2018-2030
6.3.4 Mexico Small Molecule Targeted Anti-cancer Drug Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Small Molecule Targeted Anti-cancer Drug Revenue, 2018-2030
6.4.2 Germany Small Molecule Targeted Anti-cancer Drug Market Size, 2018-2030
6.4.3 France Small Molecule Targeted Anti-cancer Drug Market Size, 2018-2030
6.4.4 U.K. Small Molecule Targeted Anti-cancer Drug Market Size, 2018-2030
6.4.5 Italy Small Molecule Targeted Anti-cancer Drug Market Size, 2018-2030
6.4.6 Russia Small Molecule Targeted Anti-cancer Drug Market Size, 2018-2030
6.4.7 Nordic Countries Small Molecule Targeted Anti-cancer Drug Market Size, 2018-2030
6.4.8 Benelux Small Molecule Targeted Anti-cancer Drug Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Small Molecule Targeted Anti-cancer Drug Revenue, 2018-2030
6.5.2 China Small Molecule Targeted Anti-cancer Drug Market Size, 2018-2030
6.5.3 Japan Small Molecule Targeted Anti-cancer Drug Market Size, 2018-2030
6.5.4 South Korea Small Molecule Targeted Anti-cancer Drug Market Size, 2018-2030
6.5.5 Southeast Asia Small Molecule Targeted Anti-cancer Drug Market Size, 2018-2030
6.5.6 India Small Molecule Targeted Anti-cancer Drug Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Small Molecule Targeted Anti-cancer Drug Revenue, 2018-2030
6.6.2 Brazil Small Molecule Targeted Anti-cancer Drug Market Size, 2018-2030
6.6.3 Argentina Small Molecule Targeted Anti-cancer Drug Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Small Molecule Targeted Anti-cancer Drug Revenue, 2018-2030
6.7.2 Turkey Small Molecule Targeted Anti-cancer Drug Market Size, 2018-2030
6.7.3 Israel Small Molecule Targeted Anti-cancer Drug Market Size, 2018-2030
6.7.4 Saudi Arabia Small Molecule Targeted Anti-cancer Drug Market Size, 2018-2030
6.7.5 UAE Small Molecule Targeted Anti-cancer Drug Market Size, 2018-2030
7 Small Molecule Targeted Anti-cancer Drug Companies Profiles
7.1 Astrazeneca
7.1.1 Astrazeneca Company Summary
7.1.2 Astrazeneca Business Overview
7.1.3 Astrazeneca Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.1.4 Astrazeneca Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2018-2023)
7.1.5 Astrazeneca Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.2.4 Novartis Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Millennium Pharmaceuticals
7.3.1 Millennium Pharmaceuticals Company Summary
7.3.2 Millennium Pharmaceuticals Business Overview
7.3.3 Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.3.4 Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2018-2023)
7.3.5 Millennium Pharmaceuticals Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.4.4 Bayer Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2018-2023)
7.4.5 Bayer Key News & Latest Developments
7.5 Exelixis
7.5.1 Exelixis Company Summary
7.5.2 Exelixis Business Overview
7.5.3 Exelixis Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.5.4 Exelixis Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2018-2023)
7.5.5 Exelixis Key News & Latest Developments
7.6 Abbvie
7.6.1 Abbvie Company Summary
7.6.2 Abbvie Business Overview
7.6.3 Abbvie Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.6.4 Abbvie Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2018-2023)
7.6.5 Abbvie Key News & Latest Developments
7.7 Boehringer-Ingelheim
7.7.1 Boehringer-Ingelheim Company Summary
7.7.2 Boehringer-Ingelheim Business Overview
7.7.3 Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.7.4 Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2018-2023)
7.7.5 Boehringer-Ingelheim Key News & Latest Developments
7.8 Eisai
7.8.1 Eisai Company Summary
7.8.2 Eisai Business Overview
7.8.3 Eisai Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.8.4 Eisai Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2018-2023)
7.8.5 Eisai Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.9.4 Pfizer Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2018-2023)
7.9.5 Pfizer Key News & Latest Developments
7.10 Bristol-Myers Squibb
7.10.1 Bristol-Myers Squibb Company Summary
7.10.2 Bristol-Myers Squibb Business Overview
7.10.3 Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.10.4 Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2018-2023)
7.10.5 Bristol-Myers Squibb Key News & Latest Developments
7.11 Roche
7.11.1 Roche Company Summary
7.11.2 Roche Business Overview
7.11.3 Roche Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.11.4 Roche Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2018-2023)
7.11.5 Roche Key News & Latest Developments
7.12 Bettapharma
7.12.1 Bettapharma Company Summary
7.12.2 Bettapharma Business Overview
7.12.3 Bettapharma Small Molecule Targeted Anti-cancer Drug Major Product Offerings
7.12.4 Bettapharma Small Molecule Targeted Anti-cancer Drug Revenue in Global Market (2018-2023)
7.12.5 Bettapharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Small Molecule Targeted Anti-cancer Drug Market Opportunities & Trends in Global Market
Table 2. Small Molecule Targeted Anti-cancer Drug Market Drivers in Global Market
Table 3. Small Molecule Targeted Anti-cancer Drug Market Restraints in Global Market
Table 4. Key Players of Small Molecule Targeted Anti-cancer Drug in Global Market
Table 5. Top Small Molecule Targeted Anti-cancer Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Small Molecule Targeted Anti-cancer Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Small Molecule Targeted Anti-cancer Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Small Molecule Targeted Anti-cancer Drug Product Type
Table 9. List of Global Tier 1 Small Molecule Targeted Anti-cancer Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Small Molecule Targeted Anti-cancer Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Small Molecule Targeted Anti-cancer Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Small Molecule Targeted Anti-cancer Drug Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Small Molecule Targeted Anti-cancer Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Small Molecule Targeted Anti-cancer Drug Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2024-2030
Table 30. Astrazeneca Company Summary
Table 31. Astrazeneca Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 32. Astrazeneca Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Astrazeneca Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 36. Novartis Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Millennium Pharmaceuticals Company Summary
Table 39. Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 40. Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Millennium Pharmaceuticals Key News & Latest Developments
Table 42. Bayer Company Summary
Table 43. Bayer Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 44. Bayer Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Bayer Key News & Latest Developments
Table 46. Exelixis Company Summary
Table 47. Exelixis Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 48. Exelixis Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Exelixis Key News & Latest Developments
Table 50. Abbvie Company Summary
Table 51. Abbvie Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 52. Abbvie Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Abbvie Key News & Latest Developments
Table 54. Boehringer-Ingelheim Company Summary
Table 55. Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 56. Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Boehringer-Ingelheim Key News & Latest Developments
Table 58. Eisai Company Summary
Table 59. Eisai Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 60. Eisai Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Eisai Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 64. Pfizer Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer Key News & Latest Developments
Table 66. Bristol-Myers Squibb Company Summary
Table 67. Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 68. Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Bristol-Myers Squibb Key News & Latest Developments
Table 70. Roche Company Summary
Table 71. Roche Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 72. Roche Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 73. Roche Key News & Latest Developments
Table 74. Bettapharma Company Summary
Table 75. Bettapharma Small Molecule Targeted Anti-cancer Drug Product Offerings
Table 76. Bettapharma Small Molecule Targeted Anti-cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 77. Bettapharma Key News & Latest Developments
List of Figures
Figure 1. Small Molecule Targeted Anti-cancer Drug Segment by Type in 2022
Figure 2. Small Molecule Targeted Anti-cancer Drug Segment by Application in 2022
Figure 3. Global Small Molecule Targeted Anti-cancer Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Small Molecule Targeted Anti-cancer Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Small Molecule Targeted Anti-cancer Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Small Molecule Targeted Anti-cancer Drug Revenue in 2022
Figure 8. By Type - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
Figure 9. By Application - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
Figure 10. By Type - Global Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
Figure 12. By Application - Global Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
Figure 14. By Region - Global Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
Figure 15. By Country - North America Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
Figure 16. US Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
Figure 20. Germany Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 21. France Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
Figure 28. China Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 32. India Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
Figure 34. Brazil Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Small Molecule Targeted Anti-cancer Drug Revenue Market Share, 2018-2030
Figure 37. Turkey Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Small Molecule Targeted Anti-cancer Drug Revenue, (US$, Mn), 2018-2030
Figure 41. Astrazeneca Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Millennium Pharmaceuticals Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bayer Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Exelixis Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Abbvie Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Boehringer-Ingelheim Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Eisai Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bristol-Myers Squibb Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Roche Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Bettapharma Small Molecule Targeted Anti-cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
